Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Golli Myelin Basic Proteins Modulate Voltage-Operated Ca(++) Influx and Development in Cortical and Hippocampal Neurons.
Comparing Three Dual-Task Methods and the Relationship to Physical and Cognitive Impairment in People with Multiple Sclerosis and Controls.
Seronegative neuromyelitis optica after cardiac transplantation.
A case series of autoimmune diseases accompanied by incidentally diagnosed monoclonal gammopathy: Is there a link between the two diseases?
Medical, functional, and legal aspects of vocational rehabilitation for people with multiple sclerosis.
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis.
Functional electrical stimulation as a component of activity-based restorative therapy may preserve function in persons with multiple sclerosis.
New data confirm high efficacy of Gilenya® in achieving 'no evidence of disease activity (NEDA)' based on four key measures of MS
Acute-onset multifocal motor neuropathy (AMMN):how we meet the diagnosis.
3D models of human ERα and ERβ complexed with 5-androsten-3β,17β-diol.
From genetic associations to functional studies in multiple sclerosis.
Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica.
Evaluation of Multi-Atlas Label Fusion for In Vivo MRI Orbital Segmentation.
Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease.
MAPT gene rs1052553 variant is not associated with the risk for multiple sclerosis.
Is MS an inflammatory or primary degenerative disease?
Exercising away the blues: can it help multiple sclerosis-related depression?
Involvement of Notch1 inhibition in serum-stimulated glia and oligodendrocyte differentiation from human mesenchymal stem cells.
Nogo-Receptor 1 Deficiency Has No Influence on Immune Cell Repertoire or Function during Experimental Autoimmune Encephalomyelitis.
Intractable vomiting as an initial presentation of lupus-related neuromyelitis optica.
Therapeutic Advances in Pediatric Multiple Sclerosis.
Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor.
Quantified CSF antibody reactivity against myelin in multiple sclerosis.
[Treatment and prognosis of neuromyelitis optica(NMO)].
Acquired demyelinating disorders of central nervous system: A pediatric cohort.
Pages
« first
‹ previous
…
601
602
603
604
605
606
607
608
609
…
next ›
last »